SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-20-001553
Filing Date
2020-02-13
Accepted
2020-02-13 16:21:25
Documents
1
Period of Report
2019-08-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 4364
  Complete submission text file 0001387131-20-001553.txt   5841
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11682 EL CAMINO REAL STE 300 SAN DIEGO CA 92130
Business Address
Blunt Roshawn A. (Reporting) CIK: 0001787773 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36242 | Film No.: 20610886